To investigate the early onset of specific neuropsychiatric features and underlying mechanisms in a mouse model of fragile X-associated neuropsychiatric disorders.
Key Findings:
Adolescent 90CGG mice exhibited early-onset hyperactivity, transitioning to heightened anxiety in young adulthood, indicating a progression of symptoms.
Accumulation of intranuclear inclusions was observed in the basolateral amygdala and ventral hippocampus, suggesting a link to neuropsychiatric features.
Electrophysiological analysis showed increased gamma oscillations in the ventral hippocampus during adolescence, which may relate to behavioral changes.
Reduction of parvalbumin interneurons correlated with enhanced amygdala excitability and impaired hippocampal plasticity, highlighting cellular mechanisms involved.
Proteomic analysis revealed altered proteins associated with ADHD in adolescence and anxiety/depression in adulthood, linking molecular changes to behavioral outcomes.
Interpretation:
The study indicates a temporal progression of neuropsychiatric symptoms in CGG premutation carriers, with distinct behavioral and physiological changes linked to alterations in limbic system activity, suggesting potential targets for intervention.
Limitations:
The study primarily focuses on a specific mouse model, which may not fully represent human conditions, limiting the generalizability of findings.
Longitudinal epidemiological studies in humans are needed to validate findings and understand their implications for clinical practice.
Conclusion:
The findings provide insights into the neuropsychiatric features associated with the FMR1 premutation, highlighting the potential for reversibility of symptoms upon transgene inactivation, which could inform future therapeutic strategies.
